AIL Dixon Technologies, a Joint Venture company of Dixon Technologies (India) has entered into a Memorandum of Understanding (MoU) with Molbio for manufacturing of Truelab Quattro Real Time Quantitative micro PCR Analyzer machines to test Covid-19.
These portable machines are capable of performing 40-48 tests per day of critical infectious diseases and will be manufactured at AIL Dixon’s manufacturing facility situated at Tirupati, Andhra Pradesh.
Commenting on this occasion, Atul B Lall, Managing Director, Dixon Technologies (India) said, “We are delighted to associate with Molbio whose Truenat Beta CoV machines have been recently validated and approved by Indian Council of Medical Research (ICMR) to conduct Covid-19 tests. Molbio’s TrueNat machine is already a breakthrough technology which is capable of diagnosing Tuberculosis and more than 30 other infectious diseases including malaria, chickengunya, dengue, H1N1 etc. in less than an hour’s time as well as testing for resistance to drug rifampicin and these machines have been endorsed by World Health Organization.”
“Molbio’s testing/diagnosis machines are highly advanced and are known for their accuracy in results and we look forward to a prolific association with Molbio who are known for their fully indigenous, revolutionary and disruptive technologies in the medical world,” added Lall.